Literature DB >> 6573527

Cutaneous melanoma in relation to exogenous hormones and reproductive factors.

E A Holly, N S Weiss, J M Liff.   

Abstract

Eighty-seven women of ages 37-74, who resided in King County, Wash., and who had been diagnosed between July 1976 and November 1979 as having cutaneous malignant melanoma, were interviewed regarding prior use of estrogen-containing preparations and reproductive history. The responses were compared with those of a random sample of 863 women from the same county. Among the 61 women with superficial spreading melanoma (SSM), use of oral contraceptives for 5 years or more was more common than among controls. The estimated relative risks for users of 5-9 and 10 years or more were 2.4 and 3.6, respectively. No differences between cases and controls were noted for oral contraceptive use of 4 years or less. Giving birth to a first child after age 30 was also associated with an increased relative risk of SSM. Although the positive findings regarding oral contraceptive use and age at birth of first child must be interpreted cautiously pending results of other studies, they suggest that hormonal factors can play a role in the etiology of SSM.

Entities:  

Keywords:  Age Factors; Americas; Biology; Body Weight; Cancer; Demographic Factors; Dermatological Effects; Developed Countries; Diseases; Educational Status; Endocrine System; Estrogens--complications; Histology; Hormones; Marital Status; Maternal Age; Neoplasms; North America; Northern America; Parental Age; Physiology; Population; Population Characteristics; Religion; United States; Washington

Mesh:

Substances:

Year:  1983        PMID: 6573527

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  20 in total

Review 1.  Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?

Authors:  H Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Age at first birth and melanoma risk: a meta-analysis.

Authors:  Zhengyong Li; Mingjin Gu; Ying Cen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Cancer in pregnancy: maternal-fetal conflict.

Authors:  F S Oduncu; R Kimmig; H Hepp; B Emmerich
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

4.  Malignant melanoma and pregnancy ten questions.

Authors:  R O Dillman; L A Vandermolen; N M Barth; K J Bransford
Journal:  West J Med       Date:  1996-02

5.  Sex, pregnancy, hormones, and melanoma.

Authors:  I Jatoi; M E Gore
Journal:  BMJ       Date:  1993-07-03

Review 6.  Exogenous hormones in the aetiology of cancer in women.

Authors:  M P Vessey
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

Review 7.  Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women.

Authors:  M G Lê; P A Cabanes; V Desvignes; M F Chanteau; N Mlika; M F Avril
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

Review 8.  The relationship between oral contraceptive use, cancer and vascular disease.

Authors:  C La Vecchia; S Franceschi; P Bruzzi; F Parazzini; P Boyle
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

9.  Oral contraceptive use and risk of cutaneous malignant melanoma.

Authors:  J R Palmer; L Rosenberg; B L Strom; S Harlap; A G Zauber; M E Warshauer; S Shapiro
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

10.  Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.

Authors:  Elnaz F Firoz; Melanie Warycha; Jan Zakrzewski; Danuta Pollens; Guimin Wang; Richard Shapiro; Russell Berman; Anna Pavlick; Prashiela Manga; Harry Ostrer; Julide Tok Celebi; Hideko Kamino; Farbod Darvishian; Linda Rolnitzky; Judith D Goldberg; Iman Osman; David Polsky
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.